Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $19.36 USD
Change Today -0.62 / -3.10%
Volume 81.6K
IMDZ On Other Exchanges
As of 8:10 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Carlos V. Paya M.D., Ph.D.

Chief Executive Officer, President and Director, Immune Design Corp.
AgeTotal Calculated CompensationThis person is connected to 13 board members in 1 different organizations across 1 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. Carlos V. Paya, MD, PhD has been the Chief Executive Officer and President of Immune Design Corp. since May 2, 2011. Dr. Paya served as the President at Elan Corp. plc since November 25, 2008. Dr. Paya led the Biotechnology commercial, marketing, clinical, research and development teams since 2008. Dr. Paya joined Elan from Eli Lilly & Company, where he served as Vice President, Lilly Research Laboratories and Global Leader of the Diabetes and Endocrine Platform, ...

Read Full Background

Corporate Headquarters*

1616 Eastlake Avenue East
Seattle, Washington 98102

United States

Phone: 206-682-0645
Fax: 206-682-0648

Board Members Memberships*

Chief Executive Officer, President and Director


Universidad Complutense de Madrid
Universidad Complutense de Madrid

Other Affiliations*

Annual Compensation*

Total Annual Compensation$798,250

Stock Options*

All Other Compensation$10,400
Exercisable Options315,884
Unexercisable Options332,001
Total Number of Options647,885

Total Compensation*

Total Annual Cash Compensation$808,650
Total Short Term Compensation$798,250
Other Long Term Compensation$10,400
Total Calculated Compensation$1,339,402
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IMDZ:US $19.36 USD -0.62


Pierre-Henri Benhamou M.D.Co-Founder, Chairman and Chief Executive Officer
DBV Technologies S.A.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMMUNE DESIGN CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at